WHO Classification of Tumours of Soft Tissue and Bone, 2020.
Zhao X, Wu Q, Gong X, Liu J, Ma Y. Osteosarcoma: a review of current and future therapeutic approaches. Biomed Eng Online. 2021;20:24.
Article PubMed PubMed Central Google Scholar
Malkin D. Li-fraumeni syndrome. Genes Cancer. 2011;2:475–84.
Article PubMed PubMed Central CAS Google Scholar
Hansen MF, Koufos A, Gallie BL, et al. Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci U S A. 1985;82:6216–20.
Article PubMed PubMed Central CAS Google Scholar
Larizza L, Roversi G, Volpi L. Rothmund-Thomson syndrome. Orphanet J Rare Dis. 2010;5:2.
Article PubMed PubMed Central Google Scholar
Strauss SJ, Frezza AM, Abecassis N, et al. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2021;32:1520–36.
Article PubMed CAS Google Scholar
Jafari F, Javdansirat S, Sanaie S, et al. Osteosarcoma: a comprehensive review of management and treatment strategies. Ann Diagn Pathol. 2020;49: 151654.
Do KH, Nguyen TV, Hoang TT, et al. Histopathological response to neoadjuvant chemotherapy in patients with enneking stage ii conventional osteosarcoma of extremities: a retrospective-single institution study in Vietnam. Cancer Control. 2024;31:10732748241274188.
Article PubMed PubMed Central Google Scholar
Hu Z, Wen S, Huo Z, et al. Current status and prospects of targeted therapy for osteosarcoma. Cells. 2022;11:3507.
Article PubMed PubMed Central CAS Google Scholar
Liang W, Long H, Zhang H, et al. Bone scaffolds-based localized drugs delivery for osteosarcoma: current status and future perspective. Drug Delivery. 2024;31:2391001.
Article PubMed PubMed Central Google Scholar
Bozorgi A, Sabouri L. Osteosarcoma, personalized medicine, and tissue engineering; an overview of overlapping fields of research. Cancer Treatment Res Commun. 2021;27: 100324.
Zhang C, Hansen HM, Semmes EC, et al. Common genetic variation and risk of osteosarcoma in a multi-ethnic pediatric and adolescent population. Bone. 2020;130: 115070.
Article PubMed CAS Google Scholar
Bairoch A. The cellosaurus, a cell-line knowledge resource. J Biomol Tech. 2018;29:25–38.
Article PubMed PubMed Central Google Scholar
Welch DL, Fridley BL, Cen L, et al. Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy. Sci Rep. 2023;13:20125.
Article PubMed PubMed Central Google Scholar
Mutsaers AJ, Walkley CR. Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells? Bone. 2014;62:56–63.
Kansara M, Teng MW, Smyth MJ, Thomas DM. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;14:722–35.
Article PubMed CAS Google Scholar
Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004;9:422–41.
Gill J, Ahluwalia MK, Geller D, Gorlick R. New targets and approaches in osteosarcoma. Pharmacol Ther. 2013;137:89–99.
Article PubMed CAS Google Scholar
Horvath P, Aulner N, Bickle M, et al. Screening out irrelevant cell-based models of disease. Nat Rev Drug Discov. 2016;15:751–69.
Article PubMed CAS Google Scholar
Fusako K, Rieko O, Marimu S, et al. Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line. In Vitro Cell Dev Biol Anim. 2018;54(7):528–36.
Comments (0)